author-photo

Angus Robinson

Brighton and Sussex University Hospitals NHS Trust

25

Papers

2392

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Metastatic prostate cancer men's attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study.

2021 BMJ Open
Show All
- Source
- Cite
- Save
Citations (0)
SAPROCAN: Saracatinib (AZD0530) and docetaxel in metastatic,castrate-refractory prostate cancer (mCRPC)—A phase I/randomized phase II study by the United Kingdom National Cancer Research Institute Prostate Group.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Metastatic prostate cancer patients’ Attitudes towards Treatment of the local Tumour and metastasis Evaluative Research (IP5-MATTER): A multicentre, discrete choice experiment trial-in-progress

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (0)
ProCAID: A randomized double-blind phase II clinical trial of capivasertib (C) in combination with docetaxel and prednisolone chemotherapy (DP) in metastatic castration-resistant prostate cancer (mCRPC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Patient Reported Toxicity, Quality of Life and Biochemical Control Following HDR Brachytherapy: Outcomes from the First 2 Years of a New Service at the Sussex Cancer Centre

2019 Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness

2018 European Urology Oncology
Show All
- Source
- Cite
- Save
Citations (9)
223Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice

2018 European Journal of Nuclear Medicine and Molecular Imaging
Show All
- Source
- Cite
- Save
Citations (12)
Radium-223: Disease response and fracture assessment by whole body diffusion-weighted MRI (WB-DWMRI) in metastatic castration resistant prostate cancer (mCRPC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Abiraterone for prostate cancer not previously treated with hormone therapy

2017 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (843)
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer

2016 European Urology
Show All
- Source
- Cite
- Save
Citations (64)